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ABSTRACT 
INTRODUCTION: Lung cancer survival is low and comparatively poor in the UK. Patients 
with symptoms suggestive of lung cancer commonly consult primary care but it is unclear 
how general practitioners (GPs) distinguish which patients require further investigation. This 
study examined how patients’ clinical and socio-demographic characteristics influence GPs’ 
decisions to initiate lung cancer investigations.  
METHODS: A factorial experiment was conducted amongst a national sample of 227 English 
GPs using vignettes presented as simulated consultations. A multimedia interactive website 
simulated key features of consultations using actors (‘patients’). GP participants made 
management decisions online for six ‘patients’, whose socio-demographic characteristics 
systematically varied across three levels of cancer risk. In low-risk vignettes, investigation 
(i.e. chest X-ray ordered, computerised tomography scan or respiratory consultant referral) 
was not indicated; in medium-risk, investigation could be appropriate; in high-risk vignettes, 
investigation was definitely indicated. Each ‘patient’ had two lung cancer-related symptoms; 
one volunteered and another elicited if GPs asked. Variations in investigation likelihood were 
examined using multilevel logistic regression. 
RESULTS: GPs decided to investigate lung cancer in 74% (1000/1348) of vignettes. 
Investigation likelihood did not increase with cancer risk. Investigations were more likely 
when GPs requested information on symptoms that ‘patients’ had but did not volunteer 
(adjusted odds ratio (AOR)=3.18; 95%CI 2.27-4.70). However GPs omitted to seek this 
information in 42% (570/1348) of cases. GPs were less likely to investigate older than 
younger ‘patients’ (AOR=0.52 95%CI 0.39-0.7) and Black ‘patients’ than White (AOR=0.68; 
95%CI 0.48-0.95).  
CONCLUSIONS: GPs were not more likely to investigate ‘patients’ with high than low-risk 
cancer symptoms. Furthermore, they did not investigate everyone with the same symptoms 
equally. Insufficient data gathering could be responsible for missed opportunities in 
diagnosis. 
  
Page 1 of 46
https://mc.manuscriptcentral.com/bmjqs
BMJ Quality & Safety
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
2 
 
INTRODUCTION 
Lung cancer, the most common cancer worldwide, has comparatively poor survival in the 
UK.
1
 Most lung cancer patients first present to primary care but diagnostic delays are well 
documented: lung cancer patients have more consultations in primary care before 
investigation than many other cancers.
2
 In addition, whilst intervals from presentation to 
diagnosis have reduced for other common cancers over time, they remain unchanged for lung 
cancer.
3
 It has been suggested that missed opportunities for lung cancer diagnosis in primary 
care may contribute to poor lung cancer survival.
4
  
Primary care physicians, referred to throughout this paper as general practitioners (GPs), have 
direct access to lung cancer diagnostic tools including chest X-ray. GPs may not consider 
lung cancer as a differential diagnosis because patients with lung cancer commonly present in 
primary care with non-specific symptoms that are more often due to benign causes.
5
 Non-
specific symptoms and rare disease occurrence therefore present diagnostic difficulty for 
GPs.
6
 Reducing diagnostic delays requires an understanding of how GPs decide which 
patients with common, non-specific symptoms to investigate for lung cancer. Not only is it 
unclear how GPs decide who requires further investigation by chest X-ray or by specialist 
referral, but inequalities by patient age, gender and socioeconomic circumstances have been 
identified in retrospective analyses of routine data.
1,2,7,8
 Most previous research has examined 
the diagnostic process using retrospective data in cancer patients only,
5
 thus missing a key 
dimension, i.e. how GPs decide which patients with symptoms do not require investigation. 
Examining decision making in a standardised way in clinical practice presents substantial 
methodological challenges.
9,10
 Direct observation of real physician-patient encounters offers 
no opportunity to control patients’ clinical and socio-demographic characteristics, and so 
requires observation of very large numbers of consultations to obtain the necessary numbers 
in specific risk or demographic categories. The use of fictional patient profiles (vignettes) can 
provide a valid and efficient approach to examining clinician behaviour,
11
 and studies have 
already produced useful insights into sources of error in clinicians’ decision making 
processes, due to both patient factors (e.g. symptom characteristics)
12
 and physician factors 
(e.g. cognitive biases).
12,13 
As Blumenthal-Barby and others recognise, however, there are 
limits to the applicability of written vignettes and other vignette designs that do not simulate 
key features of real consultations.
14
 In particular, when vignettes offer little or no opportunity 
for physicians to seek information from or about the vignette patient, they can inappropriately 
frame the decision for the physician by cueing what they should notice about the patient or by 
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offering participants only a limited selection of response options. This risks priming 
participating physicians to consider certain actions, and biasing their responses. 
In this vignette study, we therefore sought to simulate key features of consultations. We 
designed a website using interactive multimedia vignettes with videos of actor ‘patients’, 
which enabled participating GPs to ask questions in their own words and receive real-time 
responses. We used this intervention in a factorial randomised experimental study to examine 
GPs’ decisions to initiate lung cancer investigation across different combinations of patient 
clinical and socio-demographic characteristics.  
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METHODS 
Design  
We constructed 36 simulated consultations comprising video vignettes of actor ‘patients’ and 
comprehensive clinical information, including previous medical history, co-morbidities and 
exami ation findings, and socio-demographic characteristics,. The symptomatic information 
provided adhered to material in the latest available National Institute for Health and Care 
Excellence (NICE) referral guidelines for suspected cancer (published in 2005),
15
 with cancer 
risk based on data from the CAPER case-control study.
16
 Each consultation was designed to 
take participating GPs approximately 10 minutes to complete so that it mirrored the length of 
a ‘real’ clinical encounter in primary care in the UK National Health Service. 
 
At the start of each ‘consultation’, a video was shown where the actor ‘patient’ volunteered a 
description of their presenting symptom. Participants could then elicit further information in 
real-time on the presenting symptom, other symptoms, and risk factors by typing in 
questions, to which they received the ‘patient’s’ video response. They could also, if they 
wished, click on a drop-down menu to obtain information on behavioural and familial risk 
factors, previous medical history, family history, socio-demographic information and 
examination findings.(Figure 1) A demonstration is available at: 
www.ucl.ac.uk/stream/media/swatch?v=c22f1a2b58b8 
 
<<FIGURE 1>>  
We applied a factorial experimental design, where GPs undertook one consultation from each 
of six clinical profiles across three lung cancer risk levels (Table 1); no GP saw the same 
actor twice. Within these constraints, allocation of GPs to vignettes was random. This 
achieved approximate balance of patient characteristics by clinical profile, gender, ethnicity, 
and socioeconomic circumstances. The study protocol is available at: 
http://www.ucl.ac.uk/dahr/research-pages/gp_study 
  
Recruitment and participation 
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Qualified GPs and registrars nearing the end of their specialist GP training were invited 
through nine Primary Care Research Networks across England in 2012 and 2013 to 
participate in a study of decision making (without explicit reference to lung cancer). Those 
that returned an expression of interest were sent further information. For GPs that wished to 
take part, their internet browsers were checked for compatibility with the study software.  
GP participants were first trained to use the on-line simulated consultations. This was done 
using a web based video in advance of the study with access to support from the research 
team during or between study consultations. Each participating GP used the study website to 
‘consult’ with six ‘patients’ and at the end of the ‘consultation’, entered their management 
plan. GPs also completed a brief questionnaire about their practice characteristics and years 
since qualifying.  
Application development 
The application’s development followed the steps recommended by Adler et al
17
 for 
developing simulations: 
1. Case concept: developing the vignette design and content 
2. Review and Revision by Content Experts 
3. Outline and Flow Development: A typical online consultation in the study 
4. Translation of content into simulation platform: vignette interactive website 
5. Pilot testing and revisions  
A detailed description of each step is given in supplementary file S1. In brief, the structure of 
the factorial experiment required 36 unique vignette combinations to cover the four 
experimental factors: known to be associated with variation in lung cancer survival, but 
whose effect on inequalities in GPs' rates of referral for investigation or to secondary care is 
uncertain
8
: 
 
• Ethnicity: three variations (White, Black Caribbean, South Asian) 
• Gender: two variations (male, female) 
• Socioeconomic circumstances: two variations (advantaged or disadvantaged) 
• Clinical risk of lung cancer: three variations (low, medium and high-risk), with two 
profiles for each level of risk. Age was not included as a separate experimental factor 
but was instead incorporated into profiles because older age increases the risk of 
cancer associated with most symptom combinations.
16
 We constructed six clinical 
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profiles, two for each risk level using different combinations of symptoms, age, and 
smoking status.(Table 1) The positive predictive values (PPV) of lung cancer were 
drawn from PPVs generated by analysis of symptom combinations in the CAPER 
case-control dataset and interpretation of these symptoms and their characteristics 
informed by the latest available NICE guidance on investigation of suspected 
cancer.
15, 16
 (described further in supplementary data) 
 
To maximise the clinical authenticity of the cases, GPs specializing in cancer diagnosis and 
non-academic GPs reviewed the proposed vignettes. The website content and functionality 
were also informed by patient representatives’ comments. For example, these influenced the 
types of responses ‘patients’ provided, because patient representatives corroborated previous 
research that patients may well not disclose certain symptoms with their doctors without 
being directly asked about them.
18 
 
The translation of content into the online study application website (virtual patient 
application) required filming actors portraying patients, creating and populating the website 
with that content. The website architecture and application software was produced by 
Athenaeum Educational Technologies. It involved the development of a bespoke system 
using natural language processing principles to recognise GPs’ free-text questions and play a 
video clip in response (see Doan et al 2014 for an explanation of the principles).
19
 This 
system was underpinned by databases on symptoms or risk factors and the features those 
symptoms (e.g. what exacerbates or relieves the symptom or how long it has been present). 
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Table 1. Components of the six different clinical profiles by risk level 
Clinical 
Profile 
Information volunteered by ‘patient’ or available onscreen 
  
Information only available if participant 
GPs asked 
Positive 
Predictive Value 
(PPV) of lung 
cancer 
Other relevant information 
Age range Smoking status Symptom 1 Symptom 2 Duration 
Low risk: Expected action = no active investigation (safety netting appropriate) 
1 
Younger  
(Late fifties) 
Non smoker Breathlessness Fatigue 1-2 weeks 0.40% 
Patient has swollen ankles, 
possibly due to heart failure  
2 
Younger  
(Late fifties) 
Smoker Chest pain Cough 1-2 weeks 1.10%   
Medium risk: Expected action = either investigation (e.g. order chest x-ray) or safety netting 
3 
Older  
(Late seventies) 
Smoker Chest pain Cough 
Uncertain  
(approx 3 weeks) 
1.70%   
4 
Older  
(Late seventies) 
Non-smoker Cough Appetite loss 
Uncertain  
(approx 3 weeks) 
2.50%   
High risk: Expected action = lung cancer investigation 
5 
Younger  
(Late fifties) 
Smoker Breathlessness Fatigue >5 weeks 3-4% 
Chronic obstructive 
pulmonary disease (COPD) 
present 
6 
Older  
(Late seventies) 
Smoker Chest pain Weight loss >5 weeks 14%   
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Analysis 
Every action performed by GPs on the website (i.e. all the questions asked of ‘patients’, drop-
down menus accessed, free-text entered in management plans) was captured by the study 
website. This information was used to measure the duration of each consultation and to 
generate three indicators about GPs’ information requests in each consultation and the capacity 
of the research application to respond to these requests: 
• data sought: average number of data items sought (questions asked or drop-down menu 
items accessed), by GP and by individual vignette  
• errors: error messages displayed as a proportion of all data items sought, calculated for 
all consultations, consultation 1 and consultations 2-6 only, assuming that in the first 
consultation GPs were familiarising themselves with the application  
• key information elicited: proportion of GPs that elicited information on the vignettes 
second, but unvolunteered, lung cancer symptom. 
GPs also had the opportunity to provide free-text comments on any aspect of the application 
in an online survey after all the consultations were completed. These comments were not 
treated as a representative survey of all participants’ experiences but were examined to 
provide insights into GPs’ experiences of the application and their perceptions of its utility as 
a research tool for eliciting the decision making process.  
The primary outcome was the proportion of ‘patients’ for whom lung cancer investigation was 
included in the management plan. This included ordering appropriate imaging, or referral for a 
specialist opinion e.g. from a respiratory consultant whether participants’ management plan 
stated this investigation was for lung cancer or not. This outcome variable was constructed 
from free-text responses entered by participants in their management plan, according to pre-
defined criteria. A clinician confirmed the validity of every constructed primary outcome.  
Data were analysed by fitting multilevel logistic regression models using Markov Chain Monte 
Carlo for estimation,
20
 allowing variation between participants and between vignettes within 
participants. This allowed for a correlation between outcomes within a given GP but 
independent outcomes for two vignettes viewed by different GPs. Estimation of odds ratios 
and 95% credible intervals was carried out using the RStan library in R version 3.0.2.
21
 
Significance testing was carried out using Wald tests based on the means and posterior 
variances of the estimates.  
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Variations in outcome were examined by ‘patient’ gender, ethnicity, socioeconomic 
circumstances and risk profile, an indicator variable for whether participants sought the second 
symptom, and GP characteristics (demographics, experience, and region). Two models were 
built in order to examine differences by a) clinical profile and b) by age. A supplementary 
analysis was conducted to examine whether findings were difficulties in obtaining information 
sought from the application, by including the indicator on errors as another covariate in each 
model. To examine selection bias, the gender and age of participating GPs and their practices’ 
cancer referral characteristics were compared with national data.
22,23
 
The required sample size was calculated on the basis that a minimum difference in 
investigations of 10% was considered of clinical importance and realistic given variations in 
cancer investigations in other studies.
24
 A response from 216 participants was sought to give 
1296 vignettes (i.e. each of the 36 vignettes viewed 36 times). Each risk and ethnic group 
would therefore be viewed 432 times, each gender and socioeconomic group 648 times. 
Assuming a 20% variance inflation factor for clustering of GPs/’patients’, 432 in each risk and 
ethnic group would give 95% power to detect a difference of 10%. For differences between 
gender and socioeconomic groups, 648 in each group would give 85% power for a difference 
of 5%.  
 
RESULTS 
Sample characteristics 
227 GPs completed the study. This was 76% of the 300 GPs who r gistered for the study and 
41% of the 556 GPs in total that initially expressed an interest in taking part(see: 
supplementary file S2A). There were no demographic differences between registered GPs 
who did and did not complete the study but GP participants were younger than the national 
GP population and practices had higher cancer referrals than non-participating practices.(See: 
supplementary file S2B)  
Out of 1362 vignettes, 14 (1%) were excluded due to missing participant demographic data in 
one GP (n=6, 0.4%), when participants asked about second symptoms but did not receive a 
response (n=4, 0.3%) or when participants did not enter a management plan (n=4, 0.3%).  
Consultation process 
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GPs spent on average 13 minutes on the first consultation and 11 minutes on consultations 2-
6 and sought 47 items of information per consultation (by asking text questions of the patient, 
looking up patient history or personal information, conducting ‘examinations’ or ‘bedside 
tests’). GPs received error messages in response to an average of 4.6% of data sought for 
consultations 2-6 (range 4-22%).(See supplementary file, S2C)  
Lung cancer investigations 
Participants initiated investigations in 1000 (74%) vignettes. There was little difference in 
investigation between low, medium and high-risk levels (72-75%) but large variation 
between clinical profiles (59-86%). There were no variations by ‘patient’ gender or 
socioeconomic circumstances but there was a gradient in investigation by ethnicity, with 
‘patients’ of Black ethnicities least and White ethnicities most likely to be investigated (71% 
vs 77%). (Table 2) 
GPs asked for additional, relevant information about second symptoms in 778 (58%) of cases 
overall with marked variation by clinical profile, ranging from 48 (21%) in Profile 1 to 214 
and 216 (95%) in Profiles 2 and 3. There was a significant interaction between seeking a 
relevant second symptom and clinical profile (p<0.001). 91% of GPs who discovered the 
presence of weight loss initiating investigation compared with just 46% who did not seek this 
information. In contrast, knowing ‘patients’ experienced fatigue did not significantly change 
the likelihood of investigation.(Table 3)  
While obtaining second symptom information was associated with more investigation 
(adjusted odds ratio (AOR): 3.18 [2.27;4.70], p<0.001), there was still under-investigation in 
‘patients’ with appetite or weight loss (Profiles 4 and 6) compared with ‘patients’ with chest 
pain and cough (Profile 3) (AORs: 0.25 [0.14;0.42], p<0.001; and 0.5 [0.29;0.91], p=0.02 
respectively).(Table 4a) GPs were less likely to investigate older than younger ‘patients’ 
(AOR: 0.52 [0.39;0.70], p<0.001), and less likely to investigate ‘patients’ of Black compared 
with White ethnicities (AOR: 0.68 [0.48;0.95], p=0.03).(Table 4b)  
Associations were similar when the variable for errors received was included. (See: 
supplementary file S2D) 
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Comments volunteered by GP participants on their experiences of the application and their 
perceptions of its utility as a research tool for eliciting the decision making process are 
summarised in S3. 
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Table 2. Frequency of lung cancer investigation 
   Investigation 
N (vignettes) 
   n % 
Total 1000 74.18 1348 
a. By 'patient' characteristic  
   
Risk level Low 339 75.00 452 
 Medium 327 72.35 452 
 High 334 75.23 444 
Clinical profile
1
 Clinical Profile 1 PPV=0.4% (younger; ns; 1-2w breathless [& fatigue]) 152 66.96 227 
Clinical Profile 2 PPV=1.1% (younger, s; 1-2w chest pain [& cough]) 187 83.11 225 
 Clinical Profile 3 PPV=1.7% (older, s; ~3w chest pain [& cough]) 195 85.90 227 
 Clinical Profile 4 PPV=2.5% (older, ns; ~3w cough [& appetite loss]) 132 58.67 225 
 Clinical Profile 5 PPV=3-4% (younger, s; >5w breathless [& fatigue]) 185 82.59 224 
 Clinical Profile 6 PPV~14% (older, s; >5w chest pain [& weight loss]) 149 67.73 220 
Gender Female 489 74.09 660 
 Male 511 74.27 688 
Socioeconomic 
circumstances 
Disadvantaged 508 74.49 682 
Advantaged 492 73.87 666 
Ethnicity White 369 76.56 482 
 Black 306 71.50 428 
 South Asian 325 74.20 438 
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2nd symptom 
elicited 
No 361 63.33 570 
Yes 639 82.13 778 
b. By GP participa t characteristic  
   
GP gender Female 425 70.48 603 
 Male 573 77.12 743 
GP age range 25-34 years 227 70.06 324 
 
35-44 years 336 72.89 461 
 
45-54 years 325 78.69 413 
 
55-64 years 102 75.00 136 
 
65 years or over/missing 8 66.67 12 
Years since 
qualifying
 
0 to 2 years ago  120 71.43 168 
2 to 5 years ago  186 69.14 269 
 5 to 10 years ago  177 73.75 240 
 10 to 20 years ago  256 77.58 330 
 20+ years ago  259 76.40 339 
Ethnicity White 583 73.89 789 
 Black 34 80.95 42 
 South Asian 296 73.63 402 
 Other/missing 90 75.63 119 
Region London 365 73.44 497 
 East of England 341 74.95 455 
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 North West 131 76.16 172 
 West Midlands 96 72.73 132 
 Surrey and Sussex 41 75.93 54 
 Locum GP 24 66.67 36 
1
 younger = late fifties; older = late seventies; s = smoker ns = non-smoker; w = weeks; [symptom] = not volunteered by patient 
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Table 3. Lung cancer investigation by profile according to whether GPs did or did not elicit symptom information  
 
 Clinical profile 
(Second 
symptom)
1
 
Second symptom  Lung cancer investigation 
Not elicited Elicited Symptom not elicited Symptom elicited Total 
n (%) n (%) n (%) 
Odds Ratio 
[95% CI] 
n (%) 
Odds Ratio 
[95% CI] 
n (%) 
1 (Fatigue) 179 (78.85) 48 (21.15) 120 (66.67) 1.00 [-] 31 (65.96) 0.94 [0.43;2.09] 152 (66.96) 
2 (Cough) 11 (4.89) 214 (95.11) 7 (63.64) 0.73 [0.16;3.18] 181 (84.19) 2.83 [1.82;4.40] 187 (83.11) 
3 (Cough) 11 (4.85) 216 (95.15) 7 (63.64) 0.93 [0.19;4.39] 189 (87.1) 3.67 [2.13;6.30] 195 (85.90) 
4 (Appetite loss) 89 (39.56) 136 (60.44) 42 (46.67) 0.38 [0.21;0.69] 91 (66.91) 0.98 [0.59;1.62] 132 (58.67) 
5 (Fatigue) 168 (75.00) 56 (25.00) 136 (80.47) 2.21 [1.31;3.72] 50 (89.29) 4.59 [2.86;7.37] 185 (82.59) 
6 (Weight loss) 112 (50.91) 108 (49.09) 52 (46.02) 0.36 [0.20;0.62] 99 (90.83) 5.69 [2.07;15.63] 149 (67.73) 
 
 
Total 570 (42.28) 778 (57.72) 364 (63.41)   641 (82.18)   1000 (74.18) 
1
 Clinical profile is formed from symptoms, smoking status and patient age 
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Table 4. Multilevel logistic regression of cancer investigation by 'patient' characteristic 
a) By clinical profile 
  
Adjusted
1
 odds ratio  
[95% CI] 
 Clinical profile (2nd 
symptom) 
1 (Fatigue) 0.62 [0.35; 1.10] 
2 (Cough) 0.65 [0.38; 1.15] 
3 (Cough) 1 
 
4 (Weight loss) 0.25 [0.14; 0.42]* 
 
5 (Fatigue) 1.64 [0.90; 3.11] 
  6 (Appetite loss) 0.50 [0.29; 0.91]* 
 Ethnicity White 1 
 
South Asian 0.86 [0.62; 1.20] 
  Black 0.67 [0.47; 0.96]* 
 Second symptom elicited 
No 1 
Yes 3.18 [2.27; 4.70]* 
 
b) By age 
 Age Younger (Late fifties) 1 
  Older (Late seventies) 0.52 [0.39; 0.70]* 
 Ethnicity White 1 
 
South Asian 0.88 [0.63; 1.27] 
  Black 0.68 [0.48; 0.95]* 
 Smoking status Non smoker 1 
 
Smoker 2.24 [1.64; 3.02]* 
 Second symptom elicited  
No 1 
Yes 2.83 [2.09; 3.83]* 
 
1
 adjusted for all other factors associated (p<0.1) with investigation in univariate analysis (i.e. 
'patient' profile and ethnicity, GP gender and age), and whether second symptom was elicited 
2
 adjusted for 'patient' profile, ethnicity, GP gender and age and whether second symptom 
was elicited 
* significant at p≤0.05  
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DISCUSSION 
Summary 
In this factorial experiment using vignettes in simulated consultations, GPs’ decisions to 
investigate lung cancer was influenced by whether they sought out additional, relevant 
clinical information about the presence of common symptoms. Even when participating GPs 
elicited sufficient information about symptoms, inequalities by age and ethnicity in 
investigation decisions remained.  
Comparisons with existing literature 
Our data were collected during 2012-2013 and our finding that GPs investigated a high 
proportion (72-75%) of cases is in line with literature from 2013.
24
 However it is higher than 
might have been expected if GPs were following the latest national guidance for suspected 
cancer investigation available during the study period.
15
 Participants may have proposed 
more tests for vignette ‘patients’ than they would in reality because they were not subject to 
the resource constraints of clinical practice or may have ordered X-rays primarily to 
investigate diagnoses other than cancer. Alternatively, they may have been aware of and 
responding to epidemiological evidence, presumed patient preferences, and policy published 
since the 2005 NICE guidance, all of which support a lower threshold for cancer 
investigation.
25-28
 Indeed, updated NICE guidance on referral of suspected cancer, published 
in 2015 (after our data were collected), include a substantially lower investigation threshold 
than that recommended in their earlier guideline,
29
 such that all our vignettes would now 
suggest investigation.  
We found that in 42% of cases, GPs did not seek additional information that would help to 
make an informed decision regarding referral and that was available on request. This accords 
to some extent with international studies of missed opportunities in cancer diagnosis.
30-31
 In 
the UK, the updated NICE guidance explicitly recognises that patients with combinations of 
common symptoms may be more likely to have lung cancer than patients with any one of 
these symptoms alone,
29,32
 but patients may not volunteer all the symptoms they experience 
in consultations, perhaps due to real or perceived time constraints in the consultation.
32
 The 
importance of data gathering for reaching a timely diagnosis was highlighted in the recent 
Institute of Medicine Report into improving diagnosis in health care.
33
 Zwaan et al’s study of 
breathlessness using expert review of medical records found evidence of inappropriately 
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selective information gathering in a third of cases with some evidence that diagnostic error 
and patient harm occurred in a proportion of these cases.
34
 Our study extends the field by 
providing objective evidence of non-clinical variations in data gathering by physicians in a 
large vignette study and demonstrates associations between gathering sufficient data and 
appropriate decision making.  
We also found that the effect of eliciting this second symptom on decision making varied by 
symptom. It made little difference whether participants knew that patients had a cough or 
fatigue, but made significant difference to decision making if participants knew of appetite 
and weight loss. For weight loss in particular (a key question when clinicians are considering 
whether cancer is a possible diagnosis), in 91% of cases where GP participants had elicited 
information about weight loss, they initiated investigation, compared with just 46% where 
GPs were unaware the patient had lost weight. It is important to acknowledge that neither in 
real life nor in the vignettes are the factors (symptom, age and smoking) that constituted each 
profile independent of one another. Therefore whilst we contend the results are interpretable 
and reliable, they are not as definitive as a randomised controlled trial results so this finding 
has to be treated with some caution. However, the finding accords with Kostopoulou et al’s 
recent ‘think aloud’ study which suggests that when physicians have an idea of cancer early 
in the consultation, they ask pertinent questions and initiate appropriate investigations to 
ensure a cancer diagnosis is reached.
35
 Therefore, it still seems likely that routinely 
questioning patients with ongoing respiratory symptoms about weight loss would expedite 
the diagnosis of some lung cancers.  
 
Our finding that GPs were less likely to investigate older ‘patients’ is consistent with several 
observational studies of primary care cancer referral and investigation.
36,37
 Scott et al’s Model 
of Pathways to Treatment proposes that as patients grow older, they are increasingly likely to 
attribute bodily changes to normal ageing processes than to disease.
38
 If clinicians also apply 
this ‘normal ageing’ heuristic, it may explain why GPs in this study were less likely to 
investigate older patients, despite knowing their symptoms. In contrast, patient experience 
survey data indicate more referral delays in younger (aged 55-64 years) than older patients 
(over 75 years). However survey data may be biased if older patients (with lower overall 
survival) were underrepresented because they had died or were too ill to participate in the 
survey (which was undertaken 6-12 months after diagnosis).
2
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We also found smaller ethnic variations in GPs’ investigation behaviour, with fewer 
investigations initiated in Black (and to some extent) South Asian ‘patients’ than White. This 
is consistent with survey data where non-White cancer patients report more referral delays 
than White patients.
2
 One possible explanation is that GPs were less ready to consider a lung 
cancer diagnosis in individual non-White ‘patients’ who presented with high-risk clinical 
profiles because they placed weight on knowledge that lung cancer risk factors and 
prevalence are lower in Black and South Asian than White populations.
39
 However, there is 
no evidence that patients of different ethnicities exposed to the same risk factors with similar 
symptoms are at different risk of lung cancer so differential investigation by ethnicity is not 
clinically warranted. Another possible explanation is that investigation likelihood is 
influenced by GPs’ ethnicity. In this study there were only seven GPs identified as Black, so 
it was not possible to examine this, but the mechanism by which observed ethnic variations in 
decision making occur remains an important question to address.  
 
Strengths and limitations 
Our novel approach, using vignettes in an interactive website that delivered real-time 
responses, obtained comprehensive information on decision making in over 99% of 
consultations and in a timeframe comparable to a typical consultation. The method simulated 
more components of the decision-making process in real time than has been achieved in 
previous studies.
40-42
 
Of equal importance is the fact that we applied a randomised, factorial, experimental design, 
with exact balance on profile and risk, and approximate balance, with random allocation, to 
GPs, on socio-demographic factors. This allowed us to examine the effects of patients’ socio-
demographic and clinical characteristics on GPs’ decision-making. We were not able to 
achieve total orthogonality in design of every patient characteristic, but the randomisation 
and approximate balance give some confidence in the general applicability of our results.  
 
Despite the advances we achieved in simulating real consultations, the on-line vignettes were 
limited mainly due to the constraints of the natural language system. These constraints meant 
the website was unable to provide responses to all GPs’ information requests. In the post-
consultation survey 12 GP participants (5%) reported difficulty in obtaining information, 
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which caused some of them frustration, and a small number (n=4, 1.8%) observed it may 
have altered their decision-making behaviour. The process itself of typing in questions may 
also have prompted GP participants to consider their clinical reasoning more than they would 
in their routine clinical practice. Conversely, the opportunity to select from the extensive 
drop-down selections of examinations without facing any of the logistical constraints faced in 
a real consultation (e.g. time required to measure weight) may have led them to seek more 
information with less consideration than they would do in routine clinical practice. However, 
it is important to note that all approaches to simulating consultations have some drawbacks. 
For example, while other vignette studies have enabled physicians to ‘ask’ questions of the 
patient, this has required a researcher to type responses online as ‘the patient’, sometimes 
resulting in longer ‘co sultations’ than real consultations.
40-42
 Moreover, there are several 
reasons why these simulations still provide valuable insights into GPs’ decision making. 
Firstly, our sensitivity analysis indicates that results were very close to the main analysis even 
after taking into account GPs’ difficulties in obtaining responses from the application. 
Secondly, shortcomings in doctor-patient communication during the clinical encounter are 
well recognised, such that patients in real consultations do not volunteer all the information 
clinicians would need to make informed decisions.
18
 Thirdly, it is the divergence from reality 
that makes simulated consultations useful for studying phenomena or circumstances not 
possible to observe or investigate in real life.
43
 In this study, this divergence enabled the 
systematic manipulation of patient characteristics to examine their effects on GPs’ decisions 
in isolation of the complex range of patient expectations and co-morbidities that might 
explain variations in decision making in real life. The divergence also meant GPs were not 
faced with the logistical and system/organisational constraints that affect referral decisions in 
practice. As a result, the findings provide insight into the cognitive processes underlying 
GPs’ decision making when the variation in system and patient factors present in real life are 
removed.  
 
There was some bias in the GP sample registering for the study in that GP participants’ 
practices had higher cancer referrals than non-participating practices, so they may be more 
ready than GPs nationally to investigate symptoms suggestive of cancer. However, there was 
no evidence to suggest participating GPs would have greater or smaller variation in decision 
making than non-participants.  
Page 20 of 46
https://mc.manuscriptcentral.com/bmjqs
BMJ Quality & Safety
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
21 
 
Another possible limitation is that the risk levels were based on positive predictive values 
from the CAPER symptom case-control dataset, which had wide and overlapping confidence 
intervals (as shown in supplementary data, S1). Therefore, the PPVs alone are not sufficient 
to conclude that clinical risk and therefore decision making should have varied by profile. 
However, even where the PPV point estimates are most disparate and confidence intervals 
overlap minimally, GPs investigated similar proportions of patients. In addition, the risk 
profiles had additional information other than PPV which should have guided decision 
making if GPs were acting in line with the latest available clinical guidance (e.g. symptom 
duration). Furthermore, our three broad categories align well with the 2015 NICE guidance. 
These equate to: risk below 1%, safety-netting; 1-3%, test in primary care if possible; over 
3% refer for specialist testing.
29
  
 
Conclusions and implications for research and practice 
This study demonstrates that GPs were not more likely to initiate cancer investigations for 
‘patients’ with higher risk symptoms. Furthermore, they do not investigate everyone with the 
same symptoms equally. It also indicates that insufficient data gathering could be responsible 
for diagnostic errors. It is not that GPs are doing a bad job: the average GP sees one patient 
with new lung cancer a year.
16
 Distinguishing symptoms indicating possible cancer from self-
limiting illness that GPs see daily, therefore is challenging. However, non-clinical variations 
in investigation could contribute to the socio-demographic inequalities in the timeliness of 
diagnosis and survival of lung cancer seen in the UK. It also marks a departure from the 
National Health Service commitment to promote equality through its services.
44
 The findings 
also have wider implications for quality and safety in healthcare internationally. According to 
the Institute of Medicine, diagnostic errors contribute to approximately 10 percent of patient 
deaths, and sufficient data gathering is an essential part of reaching a timely diagnosis.
33 
 
It is therefore incumbent on health systems to consider strategies that can be implemented in 
practice such as clinician education,
33,45
 decision support tools
25 
and the assessment of equity 
in clinical practice.  
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FIGURES AND LEGENDS 
Figure 1. Annotated screen grab from the study website showing an example ‘patient’, 
Jack Jones’ (Profile 1) thumbnail sketch: White British man, aged ~60 years 
LEGEND: ‘Jack Jones’ (Profile 1) thumbnail sketch: White British man, aged ~60 years, 
works on security in a block of offices. Non-smoker, has a history of diabetes (available 
through drop-down menu and shown in video if asked)  
• Social characteristics: Socioeconomic circumstances - not stated directly but GPs 
indicated in the accent and dress of ‘patients’ and occupation provided on a drop-
down menu. Ethnicity - listed in a drop-down menu and reflected in vignette 
patients’ accent and dress, with racial characteristics apparent in the facial features 
of the ‘patient’. All actors spoke fluent English to avoid linguistic barriers. 
• Presenting symptom (shown to all): Breathless. Never felt like this before and he 
is not sure what’s going on. It’s interfering with his life (e.g. had to get the bus 
into work rather than walking) and so wife suggested he come and check it out.  
• Second symptom (available if asked): Fatigue. Presumed this is because of 
breathlessness, but it is more severe than normal. Not sure why: work is the same 
as normal, things are no different at home, and he doesn’t feel stressed.  
• Further information on core profile characteristics (available if asked): Notice it 
particularly when active (e.g. struggle playing with the grandchildren). Also 
notice it when lying down in bed, and has had to start using one of his wife’s 
pillows. It’s been happening for 1-2 weeks (e.g. trains young boxers at the local 
gym but hasn’t been able to make boxing training for the last week and a half 
because of it). 
• Examples of additional profile information (available through drop-down menus): 
medications, heart rate, blood pressure, weight, height, joints (all OK).  
 
SUPPORTING INFORMATION FILES 
S1. Methods: Application development  
S2. Results: Additional details 
A. Participant characteristics  
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B. Comparison of sample with national GP population  
C. Characteristics of GPs' simulated consultations and experience of the application 
D. Sensitivity analysis including error messages received as a co-variable in both models 
S3. Results: GP comments on the study design 
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Annotated screen grab from the study website showing an example ‘patient’, Jack Jones’ (Profile 1) 
thumbnail sketch: White British man, aged ~60 years  
 
65x43mm (300 x 300 DPI)  
 
 
Page 27 of 46
https://mc.manuscriptcentral.com/bmjqs
BMJ Quality & Safety
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
1 
 
Supplementary file S1 
METHODS 
Steps in developing the virtual patient application 
Step 1. Case concept: developing the vignette design and content 
The factorial experimental design, informed by reviews of the literature on non-clinical 
factors affecting GP decision making and lung cancer diagnosis and survival, covered four 
experimental factors (Table 1) known to be associated with variation in lung cancer survival, 
but whose effect on inequalities in GPs' rates of referral for investigation or to secondary care 
is uncertain:
1
 
 
• Ethnicity: three variations (White, Black Caribbean, South Asian) 
• Gender: two varia ions (male, female) 
• Socioeconomic circumstances: two variations (advantaged or disadvantaged) 
• Clinical risk of lung cancer: three variations (low, medium and high risk), with two 
profiles for each level of risk. Age was not included as a separate experimental factor 
but was instead incorporated into profiles because older age increases the risk of 
cancer associated with most symptom combinations.
2
 
  
We constructed six clinical profiles, two for each risk level using different combinations of 
symptoms, age, and smoking status.(Table 2) The clinical profiles and risk levels were based 
on positive predictive values (PPV) of lung cancer from the CAPER case-control dataset and 
the latest available NICE guidance on investigation of suspected cancer. 
2 3
 This 2005 
guidance recommended investigation for symptoms present for >3 weeks - which equates to 
PPVs >1.2%, though the guidance did not specifically use PPV thresholds. The low-risk 
vignettes (Profiles 1 and 2) therefore reflected a PPV<1.2% with symptom duration of 1-2 
weeks, such that investigation would not be indicated (Table 2). Investigation would be 
clearly indicated for ‘high-risk vignettes (Profiles 5 and 6), which reflected a PPV>3% with 
symptom duration more than 5 weeks. In the medium-risk vignettes (Profiles 3 and 4, 
PPV=1.7-2.5%), investigation would be consistent with guidance but information on 
symptom duration was kept intentionally vague so “safety-netting” (i.e. a back-up plan if 
symptoms persist or escalate) without active investigation could also be appropriate. The first 
symptom was volunteered by the ‘patient,’ the second only elicited if GPs specifically asked. 
In Profile 1 (low risk), symptoms and co-morbidities unrelated to lung cancer, to deflect GPs 
from the primary purpose of the study. 
 
For each clinical profile a comprehensive set of additional information was developed to 
include: 
• Medical records for each of the ‘patients’; similar to what GPs would find in their own 
clinical system. These incorporated information on socio-demographic and lifestyle 
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characteristics, past medical history and medication, and a recent consultation history. 
Consistent with what would be expected for patients of their age, many 'patients' had co-
morbidities; but these were selected so in most cases they did not alter the patient’s 
likelihood of lung cancer. 
• Results of examinations and tests that GPs might perform: including tests unrelated to the 
risk profile symptoms to avoid priming GPs' behaviour. In most cases results were the 
same for all ‘patients’ with that profile, although some varied according to 'patient' 
ge der. The respiratory and cardiovascular examinations were unremarkable for all six 
profiles to ensure we were studying GPs' responses to the presence/absence of symptoms, 
rather than to positive examination findings.  
 
Step 2. Review and Revision by Content Experts 
To maximise the clinical authenticity of the cases, GPs specializing in cancer diagnosis and 
non-academic GPs reviewed the proposed vignettes, which were then revised following their 
comments. The website content and functionality were also informed by patient 
representatives’ comments. This led to the inclusion of non-smokers because of the risk of 
diagnostic delay if GPs are less likely to suspect cancer in this group. It also directly 
informed the types of responses ‘patients’ provided, where patient representatives 
corroborated previous research that patients may well not disclose certain symptoms with 
their doctors without being directly asked about them.
 
 
Step 3. Outline and Flow Development: A typical consultation in the study 
We developed the outline flow of a typical consultation on the application, the duration of 
which would be determined by what the GP sought to find out:  
• GP enters “waiting room” and clicks on “Patient” link 
• GP selects question “What seems to be the trouble?” 
• Video plays where the 'patient' volunteers their first symptom; the view is a head shot of 
'patient' in GP consulting room.  
• GPs can find out additional information through: 
o asking the 'patient' questions (e.g. on the nature of a symptom, presence of other 
symptoms). ‘Patient’ videos then play giving the GP requisite information. If the 
system was unable to provide a meaningful response, users receive an error 
message.  
o consulting medical records (e.g. on previous consultations, medications),  
o performing examinations (e.g. blood pressure, with findings provided as text).  
• GP selects “Make the final note” where they enter ideas about diagnosis (main, possible, 
possible but unlikely) and their management plan.  
• The GP completes six such consultations over ~3 weeks.  
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Table 1: Each of the 36 vignettes combinations representing the four experimental factors: gender, socioeconomic circumstances, 
ethnicity, and risk level (across two clinical profiles) 
  Low risk (PPV <1.2%)   Medium risk (PPV = 1.7-2.5%)   High risk (PPV ≥ 3%)   
  
Clinical Profile 1 
PPV=0.4 [0.1-
3.1] 
Clinical Profile 2 
PPV=0.4 [0.1-
3.1] 
  
Clinical Profile 3 
PPV=0.4 [0.1-
3.1] 
Clinical Profile 4 
PPV=0.4 [0.1-
3.1] 
  
Clinical Profile 5 
PPV=0.4 [0.1-
3.1] 
Clinical Profile 6 
PPV=0.4 [0.1-
3.1]   
D
i
s
a
d
v
a
n
t
a
g
e
d
 
 
1. South 
Asian 
2. South 
Asian   
3. South 
Asian 
4. South 
Asian   
5. South 
Asian 
6. South 
Asian   
7. Black 8. Black   9. Black 10. Black   11. Black 12. Black   
13. White 14. White   15. White 16. White   17. White 18. White   
                    
A
d
v
a
n
t
a
g
e
d
 
19. South 
Asian 
20. South 
Asian   
21. South 
Asian 
22. South 
Asian   
23. South 
Asian 
24. South 
Asian   
25. Black 26. Black   27. Black 28. Black   29. Black 30. Black   
31. White 32. White   33. White 34. White   35. White 36. White   
                    
Key:  Male Female 
 
 
Table 2. Components of the six different clinical profiles by risk level 
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Clinical 
Profile 
Information volunteered by ‘patient’ or available 
onscreen 
  
Information only available if 
participant GPs asked 
Positive 
Predictive Value 
(PPV) of lung 
cancer 
Other relevant 
information 
Age range Smoking status Symptom 1 Symptom 2 Duration 
Low risk: Expected action = no active investigation (safety netting appropriate) 
1 
Younger  
(Late fifties) 
Non smoker Breathlessness Fatigue 1-2 weeks 0.40% 
Patient has swollen ankles, 
possibly due to heart 
failure  
2 
Younger  
(Late fifties) 
Smoker Chest pain Cough 1-2 weeks 1.10%   
Medium risk: Expected action = either investigation (e.g. order chest x-ray) or safety netting 
3 
Older  
(Late seventies) 
Smoker Chest pain Cough 
Uncertain  
(approx 3 weeks) 
1.70%   
4 
Older  
(Late seventies) 
Non-smoker Cough Appetite loss 
Uncertain  
(approx 3 weeks) 
2.50%   
High risk: Expected action = lung cancer investigation 
5 
Younger  
(Late fifties) 
Smoker Breathlessness Fatigue >5 weeks 3-4% 
Chronic obstructive 
pulmonary disease 
(COPD) present 
6 
Older  
(Late seventies) 
Smoker Chest pain Weight loss >5 weeks 14%   
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Step 4. Translation of vignette content into simulation platform: the virtual patient 
application website 
The translation of content into the virtual patient application website required filming actors 
portraying patients, creating and populating the website with that content. Twelve actors with 
medical role-playing experience were each filmed playing three ’patients’ in a studio 
resembling a GP's consulting room. Actors were selected to fulfil the 'patient’ template of the 
factorial design, i.e. every combination of three ethnicities and male/female across the two 
age groups (58/59 year olds, and 78/79 years). Each actor received a detailed brief for three 
'patients'. This contained profile information (e.g. symptom presentation and features) plus 
details relating to the specific character (e.g. occupation). Actors represented the socio-
economic circumstances of their 'patient’ profiles through appearance (e.g. clothing, 
hairstyle, makeup), accent and information about their occupation/lifestyle. In each case 
actors started with an introduction to their presenting symptom - how one might answer a 
GP's initial question, "What seems to be the trouble?" – and continued with responses to 
additional questions about specific features of the presenting symptom, additional symptoms 
and their features, and other relevant subjects (e.g. smoking status). Actors were asked to 
describe these symptoms in their own words but had example scripts provided by patient 
representatives of how real patients might describe their experiences and sensations. To 
ensure consistency in content across all the vignettes, the researchers used checklists to 
ensure the actors had mentioned all the details relevant to their profiles.  
 
The website architecture and application software was produced by Athenaeum Educational 
Technologies. It involved the development of a bespoke system using natural language 
processing principles to recognise GPs’ free-text questions and play a video clip in response 
(see Doan et al 2014 for an explanation of the principles).
4
 This system was underpinned by 
databases on symptoms or risk factors and the features those symptoms (e.g. what 
exacerbates or relieves the symptom or how long it has been present). Each database was 
populated with a set of key words (including common typographical errors) which GPs might 
use to ask about the existence and features of these symptoms, see Table 3 for an example. 
The key words were initially developed by the research team in consultation with content 
experts and subsequently extended to enable the system to respond to the language and 
content of questions asked by GPs in pilots. Finally, the website was populated for each 
vignette with: 
• Over 300 videos of the 'patient' actors describing symptoms and main risk factor 
responses to provide answers to GPs’ typed in questions. This included a generic “No” or 
“Don’t understand” where there was no clinically relevant information available.  
• Text (available as drop-down menu) for all other aspects. 
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Table 3. Database example: Key words for Dyspnoea (symptom) and onset (feature) 
 
symptom or risk 
factor 
shortness 
breathless 
breathlessness 
breathe 
dyspnoea 
puff 
short of breath 
lost breath 
lose breath 
catch breath 
breatlessness 
breatless 
breathing 
difficulty 
breathing 
trouble breathing 
out of breath  
Onset what brings 
exacerbates 
what triggers 
makes it happen 
start to happen 
causes 
exacerbate 
aggravate 
aggravates 
agrivate 
aggrivate 
agrivates 
aggrivates 
especially bad 
aggrevate 
aggrevates 
makes it worse 
exacerbation 
pleuritic 
plueritic 
deep breath 
taking a breath 
take a breath 
breathing in 
breathe in 
breath in 
 
Step 5. Pilot testing 
Three pilot stages were conducted to identify changes needed to content, functionality and 
design. In stage 1, researchers were present whilst three GPs tried up to four online 
consultations to identify any problems in using the application and where additional vignette 
content was needed. In stage 2, GPs (n=7) conducted up to four online consultations 
remotely. After their pilot, they participated in a telephone interview with a researcher to 
provide feedback on the intuitiveness of the application, credibility of the vignettes, the 
consultation process and the extent to which they were able to use similar reasoning as in 
their day-to-day practice. In stages 1 and 2, researchers (JMc, RS, JS) reviewed participants’ 
log forms to identify where GPs’ questions led to an error message or an inappropriate video 
response. Revisions to the website databases and functionality were revised in response. In 
stage 3, researchers not connected with the study (n=10) conducted up to four consultations 
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to check whether errors from pilots 1 and 2 had been corrected. See S1 for details of revisions 
made as a result of the pilots.  
We made changes following pilots to the appearance, content, and functionality of the 
application:  
o Appearance: We altered the design after the first pilots to ensure GPs could see 
all the opportunities to find out information on onscreen without scrolling down 
and changed the colour scheme in response to pilot feedback. 
Content: In response to GP feedback in the early pilots, we filmed longer 'patient' 
clips describing symptoms (from 15-30 secs to 45-60 secs) with less relevant 
clinical information (from describing the nature and frequency of symptoms to 
just reporting presence of symptom and instead recounting effects on daily life). 
In addition, we added more content for each profile was developed and filmed to 
provide answers to a wider range of questions. 
Function: Using the log file data from the plots, the symptom and features 
databases were extended and refined to enable the website to provide more 
meaningful answers to GPs’ questions.  
There were limitations in natural language function that could not be further 
overcome. For example the application required GPs to repeat the name of the 
symptom they were asking about in all their questions (e.g. 'how long have you 
had chest pain' or 'what makes the breathlessness worse') which does not 
realistically mimic spoken conversation. We used data from the log files on where 
these caused GPs to get error responses in the pilots to inform development of a 
help video and PDF that GPs could access whilst using the application. We also 
provided GPs with feedback after their first 'consultation' to reduce the likelihood 
that they missed key information in future 'consultations' because of repeated 
error.  
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Profile 1: complete vignette 
The description below illustrates the information available for each profile and how GP participants could access it. It is shown for the first 
vignette profile, the ‘deflecting’ vignette, where the risk of lung cancer is lowest and the most probable diagnosis is heart failure  
 
 
Thumbnail: ‘Jack Jones’ White British man, aged ~60 years, 
works on security in a block of offices. Non-smoker, has 
diabetes and a history of depression,  
 
 
Data item Accessed by Information Format 
Presenting symptom Video – Displayed when 
participant clicked on default 
question on screen 
Breathless Patient account: Never felt like this before and he is not sure 
what’s going on. It’s interfering with his life (e.g. had to get 
the bus into work rather than walking) and so wife suggested 
he come and check it out.  
 
Second symptom Video – Displayed if participant 
used text box to ask a direct 
question about presence of 
symptom.  
 
 Synonyms recognised included: 
tiredness, tired 
Energy, lethargic, lethargy, 
Fatigue Patient account: Presumed this is because of breathlessness, 
but it is more severe than normal. Not sure why: work is the 
same as normal, things are no different at home, and he 
doesn’t feel stressed. 
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drained, exhaustion 
Exhausted, fatigue, fatigued, 
sluggish, knackered 
pooped 
Further information 
on symptom 
characteristics 
Video – Displayed if participant 
used text box to ask a direct 
question about characteristics of 
the symptom. 
For breathlessness, questions that 
could be addressed included: How 
long have you been breathless? 
What makes it better? 
What makes it worse? How far can 
you walk? 
Is it worse on exercise? 
Is it worse when you lie down? 
Does it stop your normal activities? 
Can you carry things? 
Have you ever had this before? 
Do you have chest pain? 
Do you have swollen ankles? 
Have you had calf swelling? 
Do you have asthma? 
Do you have COPD? 
Are you a smoker? 
Do you have heavy periods?) 
  
• Duration 
• Onset 
• Offset 
• Frequency 
• Effect of: 
exercise, 
lying down 
• life 
changes 
• Diet, bowel 
• Position 
(of pain) 
• Illness 
ideas 
• Family 
history 
• Medication 
• Related 
symptoms 
 
Patient account: Notice it particularly when active (e.g. 
struggle playing with the grandchildren). Also notice it when 
lying down in bed, and has had to start using one of his wife’s 
pillows. It’s been happening for 1-2 weeks (e.g. trains young 
boxers at the local gym but hasn’t been able to make boxing 
training for the last week and a half because of it). 
Information available from drop-down menus 
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Patient information Comments  
Name Jack Jones Consistent with ethnicity and socioeconomic circumstances 
Date of birth 19.05.1954  
Gender Male Also evident from patient video 
   
Address (first line) xxx Consistent with socio-economic circumstance as far as possible… 
Ethnicity White Also evident from patient video (dress, accent) 
Occupation Security guard Also available as patient video (in response to questions about occupation, job 
etc) 
   
Lifestyle factors   
Smoking status Never smoked Also available as video if patient asked through text box 
Units of alcohol per 
week 
25 units Consistent with socioeconomic and ethnicity profile and set so as not to raise 
suspicion that alcohol misuse caused symptoms. 
BMI xx kg/m² See weight 
Family history None recorded  
 
 
Systems Examinations  Information 
Abdomen (including rectal) Soft and non tender. No abnormalities detected. 
Breast Normal.  
Cardiovascular system (note to us, include heart 
rate/rhythm) 
Heart rate 72 beats/minute. Regular rhythm. Normal hearts sounds. No sacral or 
peripheral oedema.  
ENT examination No abnormality detected. 
Eye examination (including fundoscopy) No abnormality detected. 
Foot examination Pulses palpable. Sensation normal. 
Genitalia examination No abnormality detected. 
Heart rate/rhythm Heart rate 72 beats/minute. Regular rhythm. 
Nail examination All nails appear normal. 
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Neurological examination, central (including cranial 
nerves) 
No abnormality detected. 
Neurological examination, peripheral No abnormality detected. 
Peripheral pulses All pulses palpable. No abnormality detected. 
Respiratory rate 14 breaths/minute. 
Respiratory system  Rate: 14 breaths/minute. No peripheral or central cyanosis. Good chest 
movement. Chest clear. 
Joint examination, cervical spine Good range of pain-free movement. 
Joint examination, shoulder Both joints normal in appearance and movement. 
Joint examination, elbow Both joints normal in appearance and movement. 
Joint examination, wrist Both joints normal in appearance and movement. 
Joint examination, hand Joints normal in appearance and movement. 
Joint examination, thoraco-lumbar spine Normal gait. Good range of pain-free movement. 
Joint examination, hip Both joints normal in appearance and movement. 
Joint examination, knee Both j ints normal in appearance and movement. 
Joint examination, ankle Both joints normal in appearance and movement. 
Joint examination, foot Joints normal in appearance and movement. 
  
Bedside tests Information 
Blood glucose 6.7 mmol/L 
Blood pressure 140/80 mmHg  
Cultures Sputum sample provided and sent to laboratory 
Height 180cm (men); 163cm (women) 
Peak flow 575l/min (men); 390l/min (women) 
Swabs Swabs taken and sent to laboratory 
Temperature 36.5⁰C 
Urinalysis Urinalysis normal 
Weight What seems reasonable for actor/actress 
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Significant medical history Information 
Co-morbidities & date of diagnosis Diabetes mellitus 24.11.09 
 Depression 05.01.11 
 Allergies None recorded 
  
Current medication Information 
Drug name, dose, instructions for use Metformin 500mg bd 
 Fluoxetine 20mg od 
Recent appointment history  
 01.08.12 Diabetes Review 
Taking metformin 500mg bd, no problems. BP: 140/90 (on ramipril, 
amlodipine). HbA1c: 7.1. Normal FBC, renal function, cholesterol. Foot check: 
normal sensation. 
 25.10.11. Cellulitis. Cellulitis L great toe (following cut). Apyrexial, does not 
appear unwell. Rx: flucloxacillin 250mg and penicillin (V) 250mg qds (7 day 
course). Advised to return if not resolving in 5 days. 
09.08.11 Diabetes Review Taking metformin 500mg bd, no problems. HbA1c: 
7.5. Foot check: normal. Discussed dietary compliance. 
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S2 Additional results 
 
A. GP Participant characteristics  
  
  n % 
Gender 
 Female 101 44.69 
Male 125 55.31 
Age range 
 25-34 years 54 23.89 
35-44 years 77 34.07 
45-54 years 70 30.97 
55-64 years 23 10.18 
65 years or over 2 0.88 
Years since qualifying 
 0 to 2 years ago  28 12.39 
2 to 5 years ago  45 19.91 
5 to 10 years ago  40 17.70 
10 to 20 years ago  55 24.34 
20 or more years ago  58 25.66 
Ethnicity 
 White (British, Irish, Other) 132 58.41 
South Asian (Indian, 
Bangladeshi, Pakistani or Asian 
mixed) 67 29.65 
Black (Afrian or Caribbean) 7 3.1 
Other or missing (eg Chinese) 20 8.85 
Region 
 London 81 35.84 
East of England 76 33.63 
North West 29 12.83 
West Midlands 22 9.73 
Surrey and Sussex 9 3.98 
Locum GP 6 2.65 
Total 226   
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B. Participant vs national general practice characteristics 
     
 Practice population and cancer referral characteristics 
All 
median (IQR) 
Nonparticipant 
practices 
median (IQR) 
Participant 
practices 
median (IQR) p 
Age standardised cancer referral ratio 83 (37-156) 83 (36-155) 118.5 (55.25-192) <0.001 
Proportion of practice pop’n over 65y 15.4 (11.3-18.6) 15.4 (11.4-18.6) 13.1 (8.7-18.2) 0.005 
 n 8365 8145 220(b)   
(b)N is not 226 because 6 participants were locums so could not be assigned to a 
practice 
        
GP characteristics All GPs Participants 
  n % n % 
Age 
 25-34 years 4389 12.35 53 23.66 
35-44 years 10920 30.74 78 34.82 
45-54 years 12205 34.35 69 30.80 
55-64 years +  or unknown 8013 22.55 24 10.71 
Gender 
 Female 16,723 47.07 102 45.54 
Male 18,804 52.93 124 55.36 
Total 35,527   226   
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C. Characteristics of GPs' simulated consultations and experience of the application  
  Consultation 1 Consultations 2-6 
All 
Consultations 
Median duration [IQR]  13 [10-21] minutes 11 [8-14] minutes 
 
Mean number of information requests [SD] 46.1 [19.2] 47.7 [13.9]  47.4 [13.3] 
Median % information requests resulting in 
error responses [Full range] 
3.6% [0 - 52.9] 4.6% [4.0- 22.2] 4.8% [0 - 21.1] 
n (consultations)  227 1121 1348 
Note: the error rate for all consultations is higher than both consultations 2-6 and consultation 1 because in 
consultation 1 there were more cases where errors were low or zero but numbers of questions asked were also 
low than in later consultations.  
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D. Multilevel logistic regression of cancer investigation – adjusted for error rate experienced 
by GPs 
 
  Adjusted 
odds ratio 
CI (*= p<0.05) 
    
Patient' characteristic 
  
Profile 
  
Profile 1 (PPV=0.8%) 0.30 
Profile 2 (PPV=1.1%) 0.82  [0.52; 1.3] 
Profile 3 (PPV=1.7%) 1.00 
Profile 4 (PPV=2.5%) 0.20  [0.13; 0.31]* 
Profile 5 (PPV=3-4%) 0.79  [0.49; 1.29] 
Profile 6 (PPV~14%) 0.31  [0.2; 0.46]* 
Ethnicity 
White 1.00 
South Asian 0.82  [0.62; 1.08] 
Black 0.74  [0.57; 0.99] 
Error rate
(d)
 
>10%  0.77  [0.5; 1.18] 
≤10% queries resulted in error 1.00 
 
(d)
% GP participant queries resulting in error message 
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S3. Supporting information_Results: GP comments on the study design 
Overall, 24 GPs (11.5%) who completed the GP decision making study volunteered  comments on the 
'virtual patient application' study method or design using the free text question in a survey after the 
study or directly to the study team.  
 
We share the themes emerging from these volunteered comments to provide insight into GPs’ 
experiences on participating in the study and perspectives on the study design as a tool for examining 
decision making. However, this was not a survey of all participant GPs’ views and experiences, 
therefore we cannot conclude that the views are representative of all participants or that others would 
not have expressed similar views if they have been asked directly about the study design.  
 
Difficulties extracting information expected to be there 
12 GP participants (5.3%) commented it was difficult to use the study tool to extract the information 
they would have wanted to receive. Most of these GPs commented that they experienced difficulty 
working out how to phrase questions to the 'patient' in order to play videos answering the question 
they wanted, which may have required changing their normal open questioning style: 
• 'I did not find the online consultations easy to follow. I wanted to ask questions but did not 
know how to phrase them.' [GP 77] 
• 'I found the study quite frustrating because I was often unable to ask the questions I would 
normally ask and so did not obtain as good a history as usual and so felt I was making 
decisions with only half the information I normally have available.' [GP 15] 
• 'The vignettes are out of keeping with my style of open questions, so I found this difficult to 
explore symptoms.' [GP 65] 
 
Consultation behaviour diverged from ‘real-life’ due to application difficulties 
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Four GPs (1.8%) observed their consultation behaviour in this study diverged from their normal 
behaviour in ways that might have affected their decision making, perhaps leading them to under or 
over investigate ‘patients’:  
• 'The frustration surrounding the uncertainty of the answers definitely lowered my threshold to 
refer and review again.' [GP 170] 
• 'Getting lots of no's or I don't know mean I felt a bit frustrated and gave up on the 
consultation.' [GP 77] 
• 'Wasting time trying to get the relevant history when the computer could not respond de-
motivated me to engage or care if I performed well.' [GP 112] 
• 'I felt I may have over-investigated as unable to obtain answers to [certain] questions.' [GP 
107] 
 
Differences between online simulations to real life 
Some GPs also observed that (even if they were able to receive the information they would have 
sought from a real-life patient), simulated consultations online were different in important ways to 
real life consultations. In real life, GPs have the opportunity to pick up visual cues from seeing 
patients walking into the room, they are influenced by other contextual factors and they always have 
the opportunity to see patients again:  
• 'I think a lot of what we learn comes from visual cues or other things within the consultation - 
e.g. how breathless they are walking into the room.' [GP 77] 
• 'It also makes it different when you actually see someone face to face.' [GP 187] 
• 'Each patient is an individual - your scenarios were difficult to put in a realistic context to 
make a valid assessment of what I personally would do in real life.' [GP 101] 
• 'There is a lot of contextual material in the decision to refer for tests and further opinions. 
Much of that could not be captured in these vignettes.' [GP 67] 
• 'History taking in practice is easier than the vignettes and often an option would be seeing 
[the patient] again.' [GP 139] 
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